Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Dec 27;27(8):503-511.
doi: 10.1093/pch/pxac068. eCollection 2022 Dec.

Medical management of gastro-esophageal reflux in healthy infants

[Article in English, French]
Isabelle Chevalier  1 , Carolyn E Beck  1 , Marie-Joëlle Doré-Bergeron  1 , Julia Orkin  1
Affiliations

Medical management of gastro-esophageal reflux in healthy infants

[Article in English, French]
Isabelle Chevalier et al. Paediatr Child Health. .

Abstract

Clinical symptoms attributed to gastro-esophageal reflux disease (GERD) in healthy term infants are non-specific and overlap with age-appropriate behaviours. This practice point reviews the evidence for medically recommended management of this common condition. Current recommendations to manage GERD include feeding modifications such as thickening feeds or avoiding cow's milk protein. There is limited evidence for pharmacological management, including acid suppressive therapy or prokinetic agents, with the risks of such treatments often outweighing possible benefits due to significant safety and side effect concerns. Acid-suppressive therapy should not be routinely used for infants with GERD and is most likely to be useful in the context of symptoms that suggest erosive esophagitis. Evidence for managing symptoms attributed to GERD in otherwise healthy term infants less than 1 year of age is presented, and the over-prescription of medications in this population is discouraged. Anticipatory guidance regarding the natural resolution of reflux symptoms is recommended.

Keywords: Children; Gastroesophageal reflux; Gastroesophageal reflux disease; H2 receptor antagonists; Infants; Prokinetics; Proton pump inhibitor.

PubMed Disclaimer

References

    1. Martin AJ, Pratt N, Kennedy JD, et al. Natural history and familial relationships of infant spilling to 9 years of age. Pediatrics 2002;109(6):1061–7. - PubMed
    1. Rosen R, Vandenplas Y, Singendonk M, et al. Pediatric gastroesophageal reflux clinical practice guidelines: Joint recommendations of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition and the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition. J Pediatr Gastroenterol Nutr 2018;66(3):516–54. https://www.naspghan.org/files/Pediatric_Gastroesophageal_Reflux_Clinica... (Accessed February 17, 2022). - PMC - PubMed
    1. Salvatore S, Hauser B, Vandemaele K, Novario R, Vandenplas Y.. Gastroesophageal reflux disease in infants: How much is predictable with questionnaires, pH-metry, endoscopy and histology? J Pediatr Gastroenterol Nutr 2005;40(40):210–5. - PubMed
    1. Vandenplas Y, Rudolph CD, Di Lorenzo C, et al. Pediatric gastroesophageal reflux clinical practice guidelines: Joint recommendations of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition (NASPGHAN) and the European Society for Pediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN). J Pediatr Gastroenterol Nutr 2009;49(4):498–547. - PubMed
    1. Qato DM, Alexander GC, Guadamuz JS, Lindau ST.. Prescription medication use among children and adolescents in the United States. Pediatrics 2018;142(3):e20181042. - PubMed